|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-2-15
|
|
pubmed:abstractText |
Clozapine is a unique antipsychotic drug, outstanding for its lack of extrapyramidal side-effects and its superior efficacy in refractory schizophrenia. However, an unambiguous concentration-response relationship has not yet been established.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0033-3158
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
152
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
80-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11041319-Adult,
pubmed-meshheading:11041319-Alleles,
pubmed-meshheading:11041319-Antipsychotic Agents,
pubmed-meshheading:11041319-Biotransformation,
pubmed-meshheading:11041319-Clozapine,
pubmed-meshheading:11041319-Cytochrome P-450 CYP2D6,
pubmed-meshheading:11041319-Female,
pubmed-meshheading:11041319-Genotype,
pubmed-meshheading:11041319-Humans,
pubmed-meshheading:11041319-Male,
pubmed-meshheading:11041319-Middle Aged,
pubmed-meshheading:11041319-Psychiatric Status Rating Scales,
pubmed-meshheading:11041319-Schizophrenia, Paranoid
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients.
|
|
pubmed:affiliation |
Department of Psychiatry, University Clinic Charité, Humboldt University, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
